Syphilis Linked to Adverse Cardiovascular Outcomes

Matched cohort study shows higher risks across vascular events and mortality

Category	Detail
Condition	Syphilis infection and its association with cardiovascular outcomes
Key Mechanisms	Syphilis independently increases risk of vascular tissue-related cardiovascular events including aortic aneurysm or dissection, ischemic and hemorrhagic stroke, peripheral artery disease, and myocardial infarction
Target Population	Patients without preexisting cardiovascular disease, including those with tertiary and late latent syphilis
Care Setting	Tertiary health care system

Syphilis infection was associated with higher rates of myocardial infarction, ischemic and hemorrhagic stroke, aortic aneurysm or dissection, and peripheral artery disease compared to matched controls.
Tertiary and late latent syphilis stages showed significant increased cardiovascular risks; no significant associations were found in primary or secondary syphilis.
Mortality risk was markedly elevated in patients with syphilis, though residual confounding may influence this finding.

Early detection of syphilis infection is critical to mitigate cardiovascular risks.
Consider cardiovascular risk assessment in patients diagnosed with syphilis, especially in tertiary and late latent stages.

Prompt treatment of syphilis to potentially reduce adverse cardiovascular outcomes.
Incorporate cardiovascular risk management strategies in syphilis care protocols.

Monitor for signs of vascular complications such as aortic aneurysm or dissection, stroke, myocardial infarction, and peripheral artery disease in syphilis patients.
Regular follow-up to assess cardiovascular health in patients with tertiary or late latent syphilis.

Increased risk of major cardiovascular events including myocardial infarction, ischemic and hemorrhagic stroke, aortic aneurysm or dissection, and peripheral artery disease associated with syphilis.
Elevated mortality risk in syphilis patients, particularly in advanced disease stages.

Patients with syphilis infection without preexisting cardiovascular disease

Data on treatment status were not available; emphasis on early detection and treatment to potentially reduce cardiovascular risks.

Screen for syphilis in populations at risk, especially in regions with high incidence.
Integrate cardiovascular risk assessment into syphilis management, particularly for tertiary and late latent stages.
Educate patients on the potential cardiovascular complications associated with untreated syphilis.
Maintain vigilance for vascular complications in syphilis patients during clinical follow-up.